DSIP (Delta sleep-inducing peptide): preparation and storage
Intended for research use only. Not a medicinal product.
Contents (8 sections)
Identity and material form
DSIP, delta sleep-inducing peptide, is the nonapeptide Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, abbreviated WAGGDASGE. The original paper established this sequence and compared synthetic DSIP with fragments and analogues [1]. Similar names or lengths do not make them equivalent. Check free terminal groups, salt form and absence of an additional label.
The name DSIP describes its research history rather than proving an effect for every batch. This page concerns a laboratory reagent. A finished formulation, dry synthetic peptide and isolated biological fraction require different specifications.
What the research context means
Schoenenberger and Monnier studied electroencephalographic changes in rabbits following intraventricular exposure; among the synthetic sequences tested, DSIP produced the specified profile [1]. This was not a study of household use or a standard injectable formulation. The protocol also specified the model, administration method and EEG analysis.
For laboratory comparison with that work, sequence integrity and fragment monitoring matter. If new chromatographic peaks appear in solution, adding more mass does not restore the original composition. A degraded stock should not be treated simply as a less concentrated stock of intact DSIP.
Solvent and final matrix
DSIP contains acidic Asp and Glu residues and an N-terminal tryptophan. These justify checking pH-dependent solubility and possible oxidative changes, but do not establish a recipe. Selection of water, buffer or an organic component must follow the batch documentation and final matrix. Water does not maintain a fixed pH in the way a buffer does.
Use a small sample and avoid unnecessary light exposure or prolonged warmth. If acid or base is proposed for dissolution, check final pH and chromatographic composition after dilution. Dissolving at an extreme pH and then neutralising does not demonstrate absence of chemical change.
Laboratory calculation example
For a mass-dilution illustration, bringing 1.50 mg of material to a final 3.00 mL gives a nominal 0.500 mg/mL. Adding 40.0 µL of this stock within a final 2.00 mL gives 0.0100 mg/mL, or 10.0 µg/mL. The final volume includes the transferred 40.0 µL. This does not recommend a concentration for an animal or cell experiment.
If the certificate establishes peptide mass, conversion to molarity can use the verified molecular weight of that form. If only total powder mass is known, retain nominal mg/mL units. Plan serial dilutions to avoid transfers below the reliable range of the pipette.
Quality checks during handling
Tryptophan permits UV detection, but absorbance alone does not separate intact DSIP from other absorbing components. A UV concentration method requires an appropriate coefficient and matrix control. Degradation checks need separation, such as HPLC, with confirmation of the relevant peak.
When comparing storage intervals, analyse matched dilutions and include a fresh control sample. Absence of visible precipitate does not exclude oxidation or hydrolysis. Filtering a changed solution again does not restore the original reagent.
For DSIP, distinguish photochemical change, enzymatic cleavage and physical loss. Tryptophan makes the first question relevant to investigate; contact with a biological matrix adds the second. If quantitative recovery falls without new peaks, examine precipitate, tube surfaces and transfer reproducibility. Absence of new peaks under one method does not establish detection of every possible product.
For analytical comparison, prepare fresh control material in the same solvent. Compare it with material after the actual working interval. This answers a question about the specific preparation process. Accelerated heating without an established relationship to real conditions cannot independently assign a storage life in weeks or months.
If precipitate appears, do not record starting mass as the concentration of sampled supernatant. Quantitative analysis of the soluble phase or repeat preparation using a supported method is needed. Dissolving residue with a different solvent creates another matrix, so the previous control and storage interval no longer describe the new sample.
Dry material and solution need separate conditions
For long-term storage of a dry synthetic peptide, use a freezer, commonly −20 °C or below, where the specification supports it. Allow the sealed vial to reach room temperature before opening so moisture does not condense on cold powder. A refrigerator at +2–8 °C can be a working option for dry material needed within a week or a month only when the supplier supports that interval. Planning to use a vial soon does not establish its shelf life.
A solution needs its own record: solvent, concentration, pH, preparation date, temperature and permitted holding time. Do not transfer the dry-material expiry to the solution. Where freezing is supported, prepare aliquots for individual experiments; thawing the remainder again needs separate validation. Bacteriostatic water contains a preservative that can change a cell-assay result and is not a default solvent for every peptide.
Practical questions
Is there one storage life for all DSIP? No: lyophilisate and solvent composition matter. Can data for a DSIP fragment be transferred to the full sequence? No; the original study specifically compared different sequences.
Is “sleep peptide” enough to identify the material? No. Sequence and specification are needed; a commercial description does not establish chemical identity.
Monograph · Product page · Certificates of analysis
General reagent preparation · Bacteriostatic water compatibility · Storage and expiry
Sources
- Schoenenberger G A, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.. 1977.
End of article
DSIP (Delta sleep-inducing peptide)
for laboratory research
Packs and current prices on the product page.
